-
Federal Patent Court revokes second Nera patent in Xiaomi dispute; all three infringement actions have now failed at first instance
Read more: Federal Patent Court revokes second Nera patent in Xiaomi dispute; all three infringement actions have now failed at first instanceThe Federal Patent Court has revoked Nera Innovations’ EP2947606, the second of three patents asserted against Xiaomi to fall at first instance. Nera must now win on appeal to achieve anything.
-
EPO appellate ruling highlights uncertainty over need to address all auxiliary requests
Read more: EPO appellate ruling highlights uncertainty over need to address all auxiliary requestsA newly published EPO appeal decision supports allowing opponents to defer arguments against unexamined auxiliary requests, highlighting continuing uncertainty in Board of Appeal case law.
-
French patent attorney’s figures show Paris patent court filings falling sharply since UPC launch
Read more: French patent attorney’s figures show Paris patent court filings falling sharply since UPC launchA French patent litigator has published data suggesting a correlation between the UPC’s arrival and falling patent case numbers before France’s sole first-instance patent court, fueling fresh discussion about the UPC’s impact on national litigation systems.
-
Apple hit with Central District of California complaint over video call patents linked to Intellectual Discovery
Read more: Apple hit with Central District of California complaint over video call patents linked to Intellectual DiscoveryApple has been targeted with other patents connected to the South Korean NPE in recent months.
-
Hisense targeted by Fortress-backed NPE asserting former TCL China Star patents in Eastern District of Texas
Read more: Hisense targeted by Fortress-backed NPE asserting former TCL China Star patents in Eastern District of TexasDebate has grown around the “anti-NPE” LOT Network recently; TCL’s withdrawal last year suggests the company is seeking more flexibility with regards to its patent strategy.
-
Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysis
Read more: Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysisThere are opportunities in the UPC, but sometimes there can be a downside. The CoA’s Fujifilm v. Kodak decision lays out a permissive approach to (German) prior use in evidentiary, substantive, and procedural terms.
-
Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff looms
Read more: Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff loomsIncyte will pay $1.25 billion upfront for Vega Therapeutics, with up to $750 million more in sales milestones. The $2.4 billion-a-year drug loses U.S. exclusivity in December 2028 after a pediatric extension.
-
UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; more
Read more: UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; moreThis is a summary of developments in and around the UPC in the calendar week of June 1, 2026.


